BMRN vs CREX · P/E 40, rev $1.76B vs rev $21.5M
Biomarin Pharmaceutical Inc (BMRN) versus Creative Realities Inc (CREX) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Creative Realities Inc (CREX) is a software - application company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported CREX revenue for 2026-06-30 was $21.5M. Net income was -$3.9M. Revenue was up 31.5% from 2026-03-31 to 2026-06-30. CREX currently screens at market cap $35.6M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. CREX currently screens at market cap $35.6M.
Not investment advice. Open the BMRN and CREX stock pages for the full models.
Not investment advice.